1.
Neuropharmacology
; 170: 108022, 2020 06 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32119885
RESUMO
The underline neuropathology of Parkinson disease is pleiomorphic and its genetic background diverse. Possibly because of this heterogeneity, no effective disease modifying therapy is available. In this paper we give an overview of the genetics of Parkinson disease and explain how this is relevant for the development of new therapies. This article is part of the special issue entitled 'The Quest for Disease-Modifying Therapies for Neurodegenerative Disorders'.